Montana second state to sue Securities America

Follows Massachusetts in targeting sales of failed MedCap notes

Aug 29, 2010 @ 12:01 am

By Bruce Kelly

Montana's commissioner of securities and insurance has sued Securities America Inc. over the sale of failed private placements, making it the second state to target the broker-dealer for selling the risky investments.

The office of the state auditor for Montana on Aug. 4 sued Securities America and a number of its top executives, including current chief executive James Nagengast, alleging that they “withheld material information regarding heightened risks” from the firm's representatives and their clients regarding notes issued by Medical Capital Holdings Inc.

Securities America, whose brokers sold $698 million of the notes from 2003 to 2008, “concealed these risks” from its brokers and their clients, the lawsuit said.

Medical Capital was charged with fraud by the Securities and Exchange Commission last summer.

In January, the Massachusetts Securities Division sued Securities America, alleging it failed to reveal pertinent information to investors about high-risk notes issued by Medical Capital.

In total, Medical Capital sold $2.2 billion of notes through dozens of independent broker-dealers, a number of which have failed or shut down. Securities America sold the largest amount of Medical Capital notes.


Securities America is also facing a handful of complaints from investors who bought Medical Capital notes and are seeking class action status. On Aug. 11, U.S. District Judge David O. Carter for the Central District of California dismissed two of those complaints. Attorneys familiar with the matter, however, said the firm cannot declare victory yet as lawyers for clients who bought Medical Capital notes will likely soon file amended complaints.

According to the Montana lawsuit, Securities America brokers sold the Medical Capital notes to non-accredited investors, meaning investors with a net worth of less than $1 million.

The Massachusetts lawsuit also alleged that Securities America brokers sold the notes to non-accredited investors.

“Every Montana client who purchased the Medical Capital private placement attested to his or her accredited status,” Janine Wertheim, senior vice president with Securities America, wrote in an e-mail.

“We were not given an opportunity to provide the state with additional information prior to the action being filed, and we have requested a hearing,” wrote Ms. Wertheim, who is one of the executives named in the Montana suit.

Meanwhile, Securities America's showdown with Massachusetts has been postponed for the second time in as many months. A hearing scheduled to begin today has been pushed back to Sept. 23.

Securities America, with 1,898 representatives and advisers, is the independent-broker-dealer arm of Ameriprise Financial Inc.

E-mail Bruce Kelly at


What do you think?

View comments

Recommended for you

Featured video


How InvestmentNews picks its Women to Watch winners

The process is laborious and exacting, but well worth it. The end result each year is an impressive group of women in the advice industry from whom others can draw inspiration.

Latest news & opinion

Meet the 2018 Women to Watch

These female financial advisers and other industry leaders are recognized for their successes and support of other women in the financial advice business.

Some good news about female recruitment in financial advice

Each of four core advisory positions tracked in InvestmentNews' benchmarking study has seen an uptick in women entrants.

10 ETFs that are up more than 35% this year

Amid the stock market carnage, there are still some funds posting big gains.

10 biggest HSA providers rated

Morningstar rated the largest plan providers as investment and spending vehicles.

Morningstar: DOL fiduciary rule reduces inflows to mutual funds with high loads

With the measure's demise, will the SEC's advice reform sustain the momentum?


Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting It'll help us continue to serve you.

Yes, show me how to whitelist

Ad blocker detected. Please whitelist us or give premium a try.


Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print